Healthcare Services

Advances in molecular diagnostics are enhancing patient care and shaping hereditary cancer testing

April 22, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Hereditary Cancer Testing Market From 2026 To 2030?

The hereditary cancer testing market has experienced significant expansion recently. This market is projected to expand from $4.75 billion in 2025 to reach $5.3 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.6%. Historical growth can be ascribed to factors such as heightened awareness regarding hereditary cancer risks, the widespread availability of next-generation sequencing platforms, an increase in diagnostic laboratory networks, an uptick in physician recommendations for genetic testing, and the development of personalized risk assessment models.

The hereditary cancer testing market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $8.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. This projected growth is driven by factors such as broader implementation of population-level genetic screening, the expanding application of AI-powered genomic analysis, the rise in preventive oncology efforts, an increasing need for economical testing options, and stronger regulatory backing for genetic diagnostic tools. Key trends during this period are expected to encompass a greater uptake of multi-gene panel testing, heightened interest in detecting cancer risk at an early stage, wider deployment of sophisticated genetic sequencing technologies, an increase in preventive testing initiatives, and improved incorporation of clinical decision support tools.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report

What Factors Are Contributing To The Growth Of The Hereditary Cancer Testing Market?

The increasing global cancer burden is anticipated to drive the hereditary cancer testing market forward. Cancer refers to a collection of diseases defined by the uncontrolled and abnormal multiplication of cells, which are capable of infiltrating and spreading to other tissues and parts of the body. In contrast, cells in a healthy organism follow a regulated cycle of growth, division, and eventual death. Hereditary cancer testing is instrumental in addressing the comprehensive burden of cancer by identifying individuals with a genetic susceptibility to specific cancers. By evaluating inherited genetic mutations and family-related risk factors, this testing aids in recognizing high-risk individuals, thereby enabling early interventions, personalized treatment strategies, and proactive preventive measures. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the number of cancer cases diagnosed in Australia increased from 160,570 in 2022 to 164,694 in 2023, marking a significant rise over the year. This upward trajectory highlights the expanding prevalence of cancer within the country. Therefore, the rise in the overall cancer burden is propelling the hereditary cancer testing market.

What Are The Main Segments Within The Hereditary Cancer Testing Market Segment Structure?

The hereditary cancer testing market covered in this report is segmented –

1) By Test Type: Multi Panel Test, Single-Site Genetic Test

2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications

3) By End user: Hospital, Clinics, Diagnostic Centers

Subsegments:

1) By Multi Panel Test: Comprehensive Genetic Panels, Targeted Gene Panels

2) By Single-Site Genetic Test: Specific Gene Testing, Familial Mutation Testing

What Trends Are Shaping The Future Of The Hereditary Cancer Testing Market?

Companies operating in the hereditary cancer testing market are increasingly focusing on advanced technologies, such as molecular diagnostic tumor testing, to improve accuracy, enhance patient results, and tailor treatment plans. Molecular diagnostic tumor testing examines a tumor’s genetic and molecular features to inform treatment decisions and forecast future developments. For instance, in February 2023, Chubb Business Services India Private Limited, an India-based global insurance company, introduced Cancer Advocate Plus. This program incorporates genetics-based testing to identify inherited genes that elevate cancer risk. Such a proactive measure enables individuals to understand their susceptibility to various cancers, facilitating timely intervention and customized care strategies.

Who Are The Companies Participating In The Hereditary Cancer Testing Market?

Major companies operating in the hereditary cancer testing market are Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.

Get The Full Hereditary Cancer Testing Market Report:

https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report

Which Region Is The Largest In The Hereditary Cancer Testing Market?

North America was the largest region in the hereditary cancer testing market in 2025. The regions covered in the hereditary cancer testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hereditary Cancer Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report

Browse Through More Reports Similar to the Global Hereditary Cancer Testing Market 2026, By The Business Research Company

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Hereditary Breast And Ovarian Cancer Syndrome Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hereditary-breast-and-ovarian-cancer-syndrome-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795